Northeast Men's Health

CLIA Laboratory Citation Details

2
Total Citations
8
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 22D2180282
Address 333 Elm St, Dedham, MA, 02026
City Dedham
State MA
Zip Code02026
Phone617 793-5000
Lab DirectorMARK LASPINA

Citation History (2 surveys)

Survey - April 9, 2025

Survey Type: Standard

Survey Event ID: O93M11

Deficiency Tags: D5209 D5805 D0000 D5209 D5805

Summary:

Summary Statement of Deficiencies D0000 A CLIA recertification survey was conducted for the Northeast Men's Health laboratory on 04/09/2025 pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. . D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: . Based on record review and interview with Testing Persons #1 (TP1) and Testing Person # 2 (TP2) on 4/09/2025, the laboratory failed to have and follow written policies and procedures to evaluate the competency of the Technical Consultant (TC) as evidenced by the following: The surveyor reviewed the competency records on 4/09 /2025 for the seven (7) laboratory personnel. The review revealed that an annual competency assessment was not performed for the former TC who was employed from 3/2024 to 3/2025. TP #1 and TP #2 confirmed in an interview on 4/09/2025 at 10:38 A.M. that an annual competency assessment had not been completed for the former TC who was hired from 3/2024 to 3/2025. The laboratory performs 2,000 PSA and 2,000 Total Testosterone tests annually. . D5805 TEST REPORT CFR(s): 493.1291(c) (c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: . Based on record review and interview with the Testing Person #1 (TP1) and Testing Person #2 (TP2) on 4/09/2025, the laboratory failed to indicate on the patient final test report the correct address of the laboratory where the test was performed as evidenced by the following: The surveyor reviewed eight (8) patient final test reports between September 2023 through April 2025 in the Electronic Medical Record (EMR), AdvancedMD. The review revealed that the laboratory failed to indicate the correct address of the laboratory location where the test was performed for four (4) out of eight (8) patient final test reports. For the four (4) patient final test reports one (1) indicated no laboratory address and three (3) indicated the laboratory's address as 11 Apex Drive, Marlborough, MA 01752. TP1 and TP2 confirmed on 4/09/2025 at 12:20 P.M. that the four (4) patient final test reports did not indicate the correct address of the laboratory where the test was performed. The laboratory performs 2,000 PSA and 2,000 Total Testosterone tests annually. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 8, 2021

Survey Type: Standard

Survey Event ID: 874011

Deficiency Tags: D0000 D5805 D5805

Summary:

Summary Statement of Deficiencies D0000 An initial CLIA certification survey was conducted for Northeast Men's Health laboratory pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: . Based on record review and interview with the Technical Consultant (TC) on 6/8 /2021, the laboratory failed to indicate on the patient final test report the correct name of the laboratory where the test was performed as evidenced by the following: The surveyor reviewed eight (8) patient final test reports between June 2020 through April 2021 in the Electronic Medical Record (EMR), AdvancedMD. The review revealed: The laboratory failed to indicate the correct name of the laboratory location where the test was performed for eight (8) out of eight (8) patient final test reports. The name of the laboratory on the patient final test reports in the AdvancedMD EMR was North East Mens Clinic. The laboratory's name on the CLIA certificate is Northeast Men's Health. The TC confirmed on 6/8/2021 at 11:38 AM that the patient final test reports did not indicate the correct name of the laboratory where the test was performed. The laboratory performs 2,000 PSA and 2,000 Total Testosterone tests annually. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access